首页 > 最新文献

Journal of Maternal-Fetal & Neonatal Medicine最新文献

英文 中文
Placental transcriptomic profiling showed disturbance of chemokine activities and lymphocyte chemotaxis in pregnancy with fetal growth restriction. 胎盘转录组分析显示胎儿生长受限的妊娠期趋化因子活性和淋巴细胞趋化性紊乱。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-01 Epub Date: 2025-10-14 DOI: 10.1080/14767058.2025.2567473
Xiaohui Li, Xin He, Jiamei Tong, Yanan Hu, Zhengpeng Li, Yi Chen

Objective: Fetal growth restriction (FGR) is a serious pathological complication associated with perinatal death and adverse pregnancy outcomes, which is largely related to placental dysfunction. This study aimed to identify FGR-related placenta transcriptomic features and provide insight into the pathologic mechanisms of FGR.

Methods: In this research, transcriptomic data were obtained by RNA sequencing on placenta samples from eight FGR patients and eight normal term-pregnant women. Differential expression analysis was used to identify the differentially expressed genes (DEGs) between groups, then function and pathway enrichment analysis by DEGs was performed. After correlation analysis between DEGs and clinical indicators of FGR, validation of DEGs by Gene Expression Omnibus (GEO) dataset was carried out. Receiver operating characteristic (ROC) analysis was used to calculate the diagnostic ability of DEG biomarkers.

Results: We identified seven candidate DEGs. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis revealed candidate DEGs primarily involved in chemokine activities and lymphocyte chemotaxis. Correlation analysis found that the expression level of DPPA4 and CTAG2 gene were significantly positively correlated with neonatal birth weight (p < 0.05). The expression level of IGSF21 was significantly negatively correlated with placenta weight, neonatal birth weight and neonatal birth weight percentile (p < 0.05). The expression level of CXCL11 showed a negative correlation with neonatal birth weight and neonatal birth weight percentile (p < 0.05). Additionally, the expression level of CXCL10 exhibited a negative correlation to neonatal birth weight percentile (p < 0.05). The expression level of HLA-DQA1, CXCL10 and CXCL11 in the GEO dataset were in good agreement with our results. We conducted the ROC analysis and found the area under the curve (AUC) values based on each DEG alone were 80% for HLA-DQA1, 79%f or CXCL11 and 76% for CXCL10, suggesting that the above three DEGs had potential significance for FGR diagnosis.

Conclusion: This study gives an insight into transcriptional features in FGR mechanism and discovers novel genes that may provide evidence for predicting and managing FGR.

目的:胎儿生长受限(FGR)是一种与围产期死亡和不良妊娠结局相关的严重病理并发症,与胎盘功能障碍有很大关系。本研究旨在确定FGR相关的胎盘转录组特征,并为FGR的病理机制提供见解。方法:对8例FGR患者和8例正常足月孕妇的胎盘样本进行RNA测序,获得转录组学数据。通过差异表达分析鉴定各组间的差异表达基因(deg),并进行deg功能和途径富集分析。通过分析基因表达基因(Gene Expression Omnibus, GEO)与FGR临床指标的相关性,对基因表达基因进行验证。采用受试者工作特征(ROC)分析计算DEG生物标志物的诊断能力。结果:我们确定了7个候选deg。基因本体(GO)和京都基因与基因组百科全书(KEGG)富集分析显示候选基因主要参与趋化因子活性和淋巴细胞趋化性。相关性分析发现,DPPA4和CTAG2基因的表达水平与新生儿出生体重呈显著正相关(p IGSF21与胎盘重量、新生儿出生体重和新生儿出生体重百分位数呈显著负相关(p CXCL11与新生儿出生体重和新生儿出生体重百分位数呈负相关)(p CXCL10与新生儿出生体重百分位数呈负相关(p HLA-DQA1;GEO数据集中的CXCL10和CXCL11与我们的结果吻合良好。我们进行了ROC分析,发现单独基于每个DEG的曲线下面积(AUC)值HLA-DQA1为80%,CXCL11为79%,CXCL10为76%,这表明上述三个DEG对FGR的诊断具有潜在的意义。结论:本研究揭示了FGR机制的转录特征,并发现了可能为FGR的预测和管理提供证据的新基因。
{"title":"Placental transcriptomic profiling showed disturbance of chemokine activities and lymphocyte chemotaxis in pregnancy with fetal growth restriction.","authors":"Xiaohui Li, Xin He, Jiamei Tong, Yanan Hu, Zhengpeng Li, Yi Chen","doi":"10.1080/14767058.2025.2567473","DOIUrl":"https://doi.org/10.1080/14767058.2025.2567473","url":null,"abstract":"<p><strong>Objective: </strong>Fetal growth restriction (FGR) is a serious pathological complication associated with perinatal death and adverse pregnancy outcomes, which is largely related to placental dysfunction. This study aimed to identify FGR-related placenta transcriptomic features and provide insight into the pathologic mechanisms of FGR.</p><p><strong>Methods: </strong>In this research, transcriptomic data were obtained by RNA sequencing on placenta samples from eight FGR patients and eight normal term-pregnant women. Differential expression analysis was used to identify the differentially expressed genes (DEGs) between groups, then function and pathway enrichment analysis by DEGs was performed. After correlation analysis between DEGs and clinical indicators of FGR, validation of DEGs by Gene Expression Omnibus (GEO) dataset was carried out. Receiver operating characteristic (ROC) analysis was used to calculate the diagnostic ability of DEG biomarkers.</p><p><strong>Results: </strong>We identified seven candidate DEGs. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis revealed candidate DEGs primarily involved in chemokine activities and lymphocyte chemotaxis. Correlation analysis found that the expression level of <i>DPPA4</i> and <i>CTAG2</i> gene were significantly positively correlated with neonatal birth weight (<i>p</i> < 0.05). The expression level of <i>IGSF21</i> was significantly negatively correlated with placenta weight, neonatal birth weight and neonatal birth weight percentile (<i>p</i> < 0.05). The expression level of <i>CXCL11</i> showed a negative correlation with neonatal birth weight and neonatal birth weight percentile (<i>p</i> < 0.05). Additionally, the expression level of <i>CXCL10</i> exhibited a negative correlation to neonatal birth weight percentile (<i>p</i> < 0.05). The expression level of <i>HLA-DQA1</i>, <i>CXCL10</i> and <i>CXCL11</i> in the GEO dataset were in good agreement with our results. We conducted the ROC analysis and found the area under the curve (AUC) values based on each DEG alone were 80% for <i>HLA-DQA1</i>, 79%f or <i>CXCL11</i> and 76% for <i>CXCL10</i>, suggesting that the above three DEGs had potential significance for FGR diagnosis.</p><p><strong>Conclusion: </strong>This study gives an insight into transcriptional features in FGR mechanism and discovers novel genes that may provide evidence for predicting and managing FGR.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"38 1","pages":"2567473"},"PeriodicalIF":1.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145294262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nutrition in infants with hypoxic-ischemic encephalopathy: insights from a single-center experience on parenteral and enteral feeding during therapeutic hypothermia. 缺氧缺血性脑病婴儿的营养:来自治疗性低温期间肠外和肠内喂养的单中心经验的见解
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-01 Epub Date: 2025-12-03 DOI: 10.1080/14767058.2025.2592375
Isaura Molina Stornelli, Nikolay Bliznyuk, Juan Carlos Roig, Josef Neu, Katherine Kisilewicz, Dhanashree Rajderkar, Livia Sura, Sujal Patel, Daniel Chong, Siena Vadakal, Taylor Edwards, Michael D Weiss

Background: Therapeutic hypothermia (TH) is standard of care for neonates ≥36 weeks with hypoxic-ischemic encephalopathy (HIE). Although intravenous fluid restriction is common, optimal strategies for parenteral and enteral nutrition remain unclear. This study evaluated the tolerance of parenteral nutrition (PN) and enteral feeding in neonates undergoing TH, as well as the impact of these interventions on clinical outcomes.

Methods: We retrospectively reviewed charts from the Florida Neonatal Neurologic Network (FN3) of neonates who underwent TH for HIE between 2012 and 2020. Collected data included demographics, neurologic assessments, nutritional strategies, laboratory values, and MRI findings. Statistical analysis was performed using one-way ANOVA, with results expressed as Kruskal-Wallis p-values.

Results: Of 170 neonates, 163 met inclusion criteria. Participants were categorized by nutritional approach: intravenous fluids (IVF), PN, or both. Neonates receiving PN had significantly higher blood urea nitrogen (BUN) during TH (p <  0.05), although values remained within acceptable limits. Lipid tolerance did not differ between groups. PN administration was associated with improved glucose regulation at 12 h (p <  0.05). Enteral feeding correlated with reduced brain injury on MRI and improved neurodevelopmental outcomes, including cognitive (p <  0.05) and motor (p <  0.05) function. Neonates receiving both PN and enteral feeding demonstrated significant recovery from malnutrition by the first outpatient follow-up (p <  0.05) and achieved full enteral feeds sooner (p <  0.05).

Conclusions: Early nutritional support, including PN and enteral feeding, appears to be well-tolerated in neonates undergoing TH for HIE. These findings suggest that providing early nutrition may enhance neurodevelopmental outcomes and promote growth during TH.

背景:治疗性低温治疗(TH)是新生儿缺氧缺血性脑病(HIE)≥36周的标准护理。虽然静脉输液限制是常见的,肠外和肠内营养的最佳策略仍不清楚。本研究评估了接受TH的新生儿肠外营养(PN)和肠内喂养的耐受性,以及这些干预措施对临床结果的影响。方法:我们回顾性地回顾了佛罗里达新生儿神经网络(FN3)中2012年至2020年间因HIE接受TH治疗的新生儿的图表。收集的数据包括人口统计、神经系统评估、营养策略、实验室值和MRI结果。统计分析采用单因素方差分析,结果用Kruskal-Wallis p值表示。结果:170例新生儿中,163例符合纳入标准。参与者按营养方法分类:静脉输液(IVF), PN或两者兼而有之。结论:早期营养支持,包括PN和肠内喂养,对接受TH治疗的HIE新生儿具有良好的耐受性。这些发现表明,早期提供营养可以改善TH期间的神经发育结果并促进生长。
{"title":"Nutrition in infants with hypoxic-ischemic encephalopathy: insights from a single-center experience on parenteral and enteral feeding during therapeutic hypothermia.","authors":"Isaura Molina Stornelli, Nikolay Bliznyuk, Juan Carlos Roig, Josef Neu, Katherine Kisilewicz, Dhanashree Rajderkar, Livia Sura, Sujal Patel, Daniel Chong, Siena Vadakal, Taylor Edwards, Michael D Weiss","doi":"10.1080/14767058.2025.2592375","DOIUrl":"https://doi.org/10.1080/14767058.2025.2592375","url":null,"abstract":"<p><strong>Background: </strong>Therapeutic hypothermia (TH) is standard of care for neonates ≥36 weeks with hypoxic-ischemic encephalopathy (HIE). Although intravenous fluid restriction is common, optimal strategies for parenteral and enteral nutrition remain unclear. This study evaluated the tolerance of parenteral nutrition (PN) and enteral feeding in neonates undergoing TH, as well as the impact of these interventions on clinical outcomes.</p><p><strong>Methods: </strong>We retrospectively reviewed charts from the Florida Neonatal Neurologic Network (FN3) of neonates who underwent TH for HIE between 2012 and 2020. Collected data included demographics, neurologic assessments, nutritional strategies, laboratory values, and MRI findings. Statistical analysis was performed using one-way ANOVA, with results expressed as Kruskal-Wallis p-values.</p><p><strong>Results: </strong>Of 170 neonates, 163 met inclusion criteria. Participants were categorized by nutritional approach: intravenous fluids (IVF), PN, or both. Neonates receiving PN had significantly higher blood urea nitrogen (BUN) during TH (<i>p</i> <  0.05), although values remained within acceptable limits. Lipid tolerance did not differ between groups. PN administration was associated with improved glucose regulation at 12 h (<i>p</i> <  0.05). Enteral feeding correlated with reduced brain injury on MRI and improved neurodevelopmental outcomes, including cognitive (<i>p</i> <  0.05) and motor (<i>p</i> <  0.05) function. Neonates receiving both PN and enteral feeding demonstrated significant recovery from malnutrition by the first outpatient follow-up (<i>p</i> <  0.05) and achieved full enteral feeds sooner (<i>p</i> <  0.05).</p><p><strong>Conclusions: </strong>Early nutritional support, including PN and enteral feeding, appears to be well-tolerated in neonates undergoing TH for HIE. These findings suggest that providing early nutrition may enhance neurodevelopmental outcomes and promote growth during TH.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"38 1","pages":"2592375"},"PeriodicalIF":1.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Buprenorphine treatment during the extended postpartum period: a survey of patient experiences. 丁丙诺啡在延长产后期间的治疗:一项患者经验的调查。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-01 Epub Date: 2025-11-02 DOI: 10.1080/14767058.2025.2578576
Bridget Galati, Heather Jacobsen, Melissa Kraus, Melissa Mills, Brittaney Vaughn, Sam Williams, Michael Wenzinger, Cynthia Rogers, Nandini Raghuraman, Jeannie Kelly
<p><strong>Objective: </strong>The late postpartum period, defined as greater than 6 weeks to 12 months, is a high-risk time for individuals with opioid use disorder (OUD). Discontinuation rates of buprenorphine treatment for OUD during this period are high. Little is known about patients' subjective experience with buprenorphine treatment during this time. We sought to assess patient treatment experience, goals, facilitators and barriers to continued buprenorphine treatment throughout the extended postpartum period.</p><p><strong>Methods: </strong>We performed a cross-sectional survey of postpartum patients who received buprenorphine treatment, including sublingual and long-acting injectable formulations, in an interdisciplinary, wrap-around clinic for maternal OUD between February 2022 through May 2023. Individuals participated in a brief electronic questionnaire comprised of multiple choice, Likert scale and open-ended questions adapted from validated surveys. Individuals were recruited to participate at each of three separate time points postpartum; <6 weeks, ≥6 weeks to 3 months, and >3 months. Descriptive statistics, Fisher exact, the Cochran-Armitage trend and chi-squared tests were used to describe survey results.</p><p><strong>Results: </strong>Fifty individuals were approached to participate in the survey, of which 25 unique postpartum individuals participated. This captured a total of 37 responses amongst all three time points. At the time of final survey completion, the average individual was 10.68 months (SD ± 7.13) postpartum. 76% self-identified as white and 24% Black or African American. The majority (88%) were prescribed sublingual buprenorphine. Most (84%) had been prescribed buprenorphine for more than three months at the time of initial survey completion. The majority (89%) of responses across all time points reported being very satisfied or satisfied with their current treatment, being satisfied with the effectiveness of their buprenorphine in reducing opioid use (98%) and with the effectiveness at reducing other substance use (54%). Top motivators for continuing treatment included individual health, ability to care for child(ren), and social support of friends or family. No differences were detected across time points. Surprisingly, the most often reported treatment goal was to discontinue buprenorphine eventually (49% of all responses). Most strongly agreed or agreed with the following statements about social supports, including that they know they take buprenorphine (100%), support their decision to take buprenorphine (89%), believe it is treatment for OUD (78%), and want them to continue treatment (78%). However, fewer (41%) strongly agreed or agreed with the following statement: the people I am close to want me to continue buprenorphine treatment long term (i.e. several years). Less than half (46%) agreed with the statement, the people I am close to know what it takes to stay sober. Barriers to buprenorphine treatment we
目的:产后晚期(定义为大于6周至12个月)是阿片类药物使用障碍(OUD)患者的高危时期。在此期间,丁丙诺啡治疗OUD的停药率很高。在此期间,患者对丁丙诺啡治疗的主观体验知之甚少。我们试图评估患者的治疗经验、目标、促进因素和障碍在整个延长的产后期间继续丁丙诺啡治疗。方法:我们对2022年2月至2023年5月期间,在一家跨学科的孕妇OUD门诊接受丁丙诺非治疗的产后患者进行了横断面调查,包括舌下和长效注射制剂。个人参与了一个简短的电子问卷,包括多项选择,李克特量表和开放式问题改编自有效的调查。研究人员在产后三个不同的时间点分别招募参与者;3个月。使用描述性统计、Fisher精确、Cochran-Armitage趋势和卡方检验来描述调查结果。结果:50名个体参与了调查,其中25名独特的产后个体参与了调查。在所有三个时间点共捕获了37个回复。最终调查完成时,平均产后10.68个月(SD±7.13)。76%的人认为自己是白人,24%是黑人或非裔美国人。大多数(88%)处方舌下丁丙诺啡。大多数(84%)在初步调查完成时已开丁丙诺啡超过三个月。所有时间点的大多数应答者(89%)报告对他们目前的治疗非常满意或满意,对丁丙诺啡减少阿片类药物使用的有效性(98%)和减少其他物质使用的有效性(54%)感到满意。继续治疗的主要动机包括个人健康、照顾孩子的能力以及朋友或家人的社会支持。各时间点间未发现差异。令人惊讶的是,最常报道的治疗目标是最终停用丁丙诺啡(占所有应答的49%)。大多数强烈同意或同意以下关于社会支持的陈述,包括他们知道他们服用丁丙诺啡(100%),支持他们服用丁丙诺啡的决定(89%),相信这是治疗OUD的方法(78%),并希望他们继续治疗(78%)。然而,很少有人(41%)强烈同意或同意以下说法:我亲近的人希望我长期(即几年)继续丁丙诺啡治疗。不到一半(46%)的人同意这一说法,我亲近的人知道如何保持清醒。丁丙诺啡治疗的障碍很少报告(12%),但包括相当大的挑战,包括COVID-19感染、缺乏交通工具和不稳定的住房。结论:在延长的产后期间,大多数患者描述丁丙诺啡治疗满意度为压倒性的积极,无论配方。然而,尽管如此,个人最常报告的目标是停止治疗,特别是在产后后期。报告社会支持的个体不同意长期(即几年)继续丁丙诺啡治疗。这些发现强调需要在延长的产后期间加强丁丙诺啡作为慢性疾病的治疗,并强调在此过程中进行教育和涉及社会支持。
{"title":"Buprenorphine treatment during the extended postpartum period: a survey of patient experiences.","authors":"Bridget Galati, Heather Jacobsen, Melissa Kraus, Melissa Mills, Brittaney Vaughn, Sam Williams, Michael Wenzinger, Cynthia Rogers, Nandini Raghuraman, Jeannie Kelly","doi":"10.1080/14767058.2025.2578576","DOIUrl":"https://doi.org/10.1080/14767058.2025.2578576","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;The late postpartum period, defined as greater than 6 weeks to 12 months, is a high-risk time for individuals with opioid use disorder (OUD). Discontinuation rates of buprenorphine treatment for OUD during this period are high. Little is known about patients' subjective experience with buprenorphine treatment during this time. We sought to assess patient treatment experience, goals, facilitators and barriers to continued buprenorphine treatment throughout the extended postpartum period.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We performed a cross-sectional survey of postpartum patients who received buprenorphine treatment, including sublingual and long-acting injectable formulations, in an interdisciplinary, wrap-around clinic for maternal OUD between February 2022 through May 2023. Individuals participated in a brief electronic questionnaire comprised of multiple choice, Likert scale and open-ended questions adapted from validated surveys. Individuals were recruited to participate at each of three separate time points postpartum; &lt;6 weeks, ≥6 weeks to 3 months, and &gt;3 months. Descriptive statistics, Fisher exact, the Cochran-Armitage trend and chi-squared tests were used to describe survey results.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Fifty individuals were approached to participate in the survey, of which 25 unique postpartum individuals participated. This captured a total of 37 responses amongst all three time points. At the time of final survey completion, the average individual was 10.68 months (SD ± 7.13) postpartum. 76% self-identified as white and 24% Black or African American. The majority (88%) were prescribed sublingual buprenorphine. Most (84%) had been prescribed buprenorphine for more than three months at the time of initial survey completion. The majority (89%) of responses across all time points reported being very satisfied or satisfied with their current treatment, being satisfied with the effectiveness of their buprenorphine in reducing opioid use (98%) and with the effectiveness at reducing other substance use (54%). Top motivators for continuing treatment included individual health, ability to care for child(ren), and social support of friends or family. No differences were detected across time points. Surprisingly, the most often reported treatment goal was to discontinue buprenorphine eventually (49% of all responses). Most strongly agreed or agreed with the following statements about social supports, including that they know they take buprenorphine (100%), support their decision to take buprenorphine (89%), believe it is treatment for OUD (78%), and want them to continue treatment (78%). However, fewer (41%) strongly agreed or agreed with the following statement: the people I am close to want me to continue buprenorphine treatment long term (i.e. several years). Less than half (46%) agreed with the statement, the people I am close to know what it takes to stay sober. Barriers to buprenorphine treatment we","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"38 1","pages":"2578576"},"PeriodicalIF":1.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145432903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors and prediction model for postpartum psychiatric disorders: a retrospective cohort study of 1418 Chinese women from 2020 to 2022. 产后精神障碍的风险因素和预测模型:2020 年至 2022 年 1418 名中国妇女的回顾性队列研究。
IF 1.7 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-01 Epub Date: 2024-12-12 DOI: 10.1080/14767058.2024.2438756
Wenxi Chen, Huan Ge, Jing Cong, Wenjie Zhou, Xiaoxia Chang, Xiaojie Quan, Jing Xia, Xincheng Tao, Danhua Pu, Jie Wu

Background: Postpartum psychiatric disorders (PPDs) have been deemed as a significant public health concern, affecting both maternal health and family dynamics. This study aimed to examine the current status of PPDs, identify the potential risk factors of PPDs, and further develop a clinical nomogram model for predicting PPDs in Chinese women.

Method: In this retrospective cohort study, 1418 postpartum women attending the routine postpartum examination at the 42nd day after delivery in Jiangsu Women and Children Health Hospital were recruited as participants from December 2020 to December 2022. The Symptom Checklist-90 (SCL-90) was utilized to assess the status of postpartum psychiatric disorders. A prediction model was constructed by multivariate logistic regression and presented as a nomogram. The performance of nomogram was measured by the receiver operating characteristic (ROC) curve, calibration curve, and decision curve analysis (DCA). The relationships between predictive factors of PPDs and SCL-90 were also evaluated using Pearson correlation analysis. The relationships between predictive factors of PPDs and SCL-90 were evaluated using Pearson correlation analysis.

Results: With the SCL-90 cutoff value of 160, the incidence of postpartum psychiatric disorders was 9.17% among Chinese urban women. The univariate and multivariate logistic regression analyses indicated that age ≤ 25 years old (OR = 10.07, 95%CI = 1.83-55.33), prenatal mood disorder (OR = 4.12, 95%CI = 1.99-8.53), invasive prenatal diagnostic procedures (OR = 4.39, 95%CI = 1.16-16.56), poor relationship with husband (OR = 2.86, 95%CI = 1.58-5.16) and poor relationship with mother-in-law (OR = 5.10, 95%CI = 2.70-9.64) were significantly associated with PPDs. A nomogram prediction model for PPDs was further constructed based on these five independent risk factors, and the area under the receiver operating characteristic curve (AUC) of the nomogram model was 0.823 (95% CI = 0.781-0.865). The calibration curves showed remarkable accuracy of the nomogram and the DCA exhibited high clinical net benefit of the nomogram. Besides, we also explored the relationships between the five risk factors and different symptom dimensions of PPDs and found that the five risk factors were almost associated with increased levels of all symptom dimensions.

Conclusions: Five psychosocial risk factors for PPDs were identified in Chinese women and the nomogram prediction model constructed based on these five risk factors could predict the risk of PPDs intuitively and individually. Systematic screening these risk factors and further conducting psychosocial interventions earlier during the pregnancy period are crucial to prevent PPDs. For future research, we intend to incorporate additional risk factors, including blood biomarkers and facial expression indicators, to refine our risk model.

背景:产后精神障碍(PPDs)已被认为是一个重大的公共卫生问题,影响着产妇的健康和家庭动态。本研究旨在探讨产后精神障碍的现状,识别产后精神障碍的潜在风险因素,并进一步建立预测中国妇女产后精神障碍的临床提名图模型:在这项回顾性队列研究中,研究人员招募了2020年12月至2022年12月期间在江苏省妇幼保健院参加产后42天常规产后检查的1418名产后妇女作为研究对象。采用症状检查表-90(SCL-90)评估产后精神障碍状况。通过多元逻辑回归建立了一个预测模型,并以提名图的形式呈现。通过接收者操作特征曲线(ROC)、校准曲线和决策曲线分析(DCA)来衡量提名图的性能。此外,还利用皮尔逊相关分析评估了 PPDs 预测因子与 SCL-90 之间的关系。使用皮尔逊相关分析评估了 PPDs 和 SCL-90 预测因子之间的关系:结果:SCL-90 临界值为 160 时,中国城市妇女产后精神障碍的发生率为 9.17%。单变量和多变量逻辑回归分析表明,年龄≤25 岁(OR = 10.07,95%CI = 1.83-55.33)、产前情绪障碍(OR = 4.12,95%CI = 1.99-8.53)、产前侵入性诊断程序(OR = 4.39,95%CI = 1.16-16.56)、与丈夫关系差(OR = 2.86,95%CI = 1.58-5.16)和与婆婆关系差(OR = 5.10,95%CI = 2.70-9.64)与 PPDs 显著相关。根据这五个独立的风险因素,进一步构建了PPD的提名图预测模型,提名图模型的接收者操作特征曲线下面积(AUC)为0.823(95% CI = 0.781-0.865)。校准曲线显示了提名图的显著准确性,DCA 显示了提名图的高临床净效益。此外,我们还探讨了五种风险因素与PPD不同症状维度之间的关系,发现五种风险因素几乎与所有症状维度的增加水平相关:结论:在中国女性中发现了五种PPD的社会心理风险因素,基于这五种风险因素构建的提名图预测模型可以直观、个体化地预测PPD的风险。系统地筛查这些风险因素,并进一步在孕期早期进行心理干预,对于预防 PPD 至关重要。在未来的研究中,我们打算加入更多的风险因素,包括血液生物标志物和面部表情指标,以完善我们的风险模型。
{"title":"Risk factors and prediction model for postpartum psychiatric disorders: a retrospective cohort study of 1418 Chinese women from 2020 to 2022.","authors":"Wenxi Chen, Huan Ge, Jing Cong, Wenjie Zhou, Xiaoxia Chang, Xiaojie Quan, Jing Xia, Xincheng Tao, Danhua Pu, Jie Wu","doi":"10.1080/14767058.2024.2438756","DOIUrl":"10.1080/14767058.2024.2438756","url":null,"abstract":"<p><strong>Background: </strong>Postpartum psychiatric disorders (PPDs) have been deemed as a significant public health concern, affecting both maternal health and family dynamics. This study aimed to examine the current status of PPDs, identify the potential risk factors of PPDs, and further develop a clinical nomogram model for predicting PPDs in Chinese women.</p><p><strong>Method: </strong>In this retrospective cohort study, 1418 postpartum women attending the routine postpartum examination at the 42nd day after delivery in Jiangsu Women and Children Health Hospital were recruited as participants from December 2020 to December 2022. The Symptom Checklist-90 (SCL-90) was utilized to assess the status of postpartum psychiatric disorders. A prediction model was constructed by multivariate logistic regression and presented as a nomogram. The performance of nomogram was measured by the receiver operating characteristic (ROC) curve, calibration curve, and decision curve analysis (DCA). The relationships between predictive factors of PPDs and SCL-90 were also evaluated using Pearson correlation analysis. The relationships between predictive factors of PPDs and SCL-90 were evaluated using Pearson correlation analysis.</p><p><strong>Results: </strong>With the SCL-90 cutoff value of 160, the incidence of postpartum psychiatric disorders was 9.17% among Chinese urban women. The univariate and multivariate logistic regression analyses indicated that age ≤ 25 years old (OR = 10.07, 95%CI = 1.83-55.33), prenatal mood disorder (OR = 4.12, 95%CI = 1.99-8.53), invasive prenatal diagnostic procedures (OR = 4.39, 95%CI = 1.16-16.56), poor relationship with husband (OR = 2.86, 95%CI = 1.58-5.16) and poor relationship with mother-in-law (OR = 5.10, 95%CI = 2.70-9.64) were significantly associated with PPDs. A nomogram prediction model for PPDs was further constructed based on these five independent risk factors, and the area under the receiver operating characteristic curve (AUC) of the nomogram model was 0.823 (95% CI = 0.781-0.865). The calibration curves showed remarkable accuracy of the nomogram and the DCA exhibited high clinical net benefit of the nomogram. Besides, we also explored the relationships between the five risk factors and different symptom dimensions of PPDs and found that the five risk factors were almost associated with increased levels of all symptom dimensions.</p><p><strong>Conclusions: </strong>Five psychosocial risk factors for PPDs were identified in Chinese women and the nomogram prediction model constructed based on these five risk factors could predict the risk of PPDs intuitively and individually. Systematic screening these risk factors and further conducting psychosocial interventions earlier during the pregnancy period are crucial to prevent PPDs. For future research, we intend to incorporate additional risk factors, including blood biomarkers and facial expression indicators, to refine our risk model.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"38 1","pages":"2438756"},"PeriodicalIF":1.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142819873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Statement of Retraction: A sandwich technique (N&H variation technique) to reduce blood loss during cesarean delivery for complete placenta previa: a randomized controlled trial. 一项随机对照试验:夹层技术(N&H变异技术)减少完全性前置胎盘剖宫产时的出血量。
IF 1.7 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-01 Epub Date: 2024-12-10 DOI: 10.1080/14767058.2025.2440150
{"title":"Statement of Retraction: A sandwich technique (N&H variation technique) to reduce blood loss during cesarean delivery for complete placenta previa: a randomized controlled trial.","authors":"","doi":"10.1080/14767058.2025.2440150","DOIUrl":"https://doi.org/10.1080/14767058.2025.2440150","url":null,"abstract":"","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"38 1","pages":"2440150"},"PeriodicalIF":1.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk prediction of excessive gestational weight gain based on a nomogram model: a prospective observational study in China. 基于nomogram模型的妊娠期体重增加风险预测:中国的一项前瞻性观察研究。
IF 1.7 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-01 Epub Date: 2024-12-25 DOI: 10.1080/14767058.2024.2440774
Linyan He, Xihong Zhou, Jiajun Tang, Min Yao, Li Peng, Sai Liu

Background: Excessive Gestational Weight Gain is a global public health problem with serious and long-term effects on maternal and offspring health. Early identification of at-risk groups and interventions is crucial for controlling weight gain and reducing the prevalence of excessive gestational weight gain. Currently, tools for predicting the risk of excessive gestational weight gain are lacking in China. This study aimed to develop a risk-prediction model and screening tool to identify high-risk groups in the early stages.

Methods: A total of 306 pregnant women were randomly selected who underwent regular obstetric checkups at a tertiary-level hospital in China between January and March 2023. Logistic regression analysis was used to construct the risk-prediction model. The goodness of fit of the model was assessed using the Hosmer-Lemeshow test, and the predictive performance was evaluated using the area under the receiver operating characteristic (ROC) curve, calibration plots, and k-fold cross-validation. R4.3.1 software was used to create a nomogram.

Results: The prevalence of excessive gestational weight gain was 50.32%. Logistic regression analysis revealed that pre-pregnancy overweight (OR = 2.563, 95% CI: 1.043-6.299), obesity (OR = 4.116, 95% CI: 1.396-12.141), eating in front of a screen (OR = 6.230, 95% CI: 2.753 - 14.097); frequency of weekly consumption of sugar-sweetened beverages/desserts/western fast food (OR = 1.948, 95% CI: 1.363-2.785); and pregnancy body image (OR = 1.030, 95% CI: 1.014-1.047) were risk factors for excessive gestational weight gain. Parity (OR = 0.452, 95% CI: 0.275 - 0.740), protective motivation to manage pregnancy body mass (OR = 0.979, 95% CI: 0.958-1), and the time of daily moderate-intensity physical activity (OR = 0.228, 95% CI: 0.113-0.461) were protective factors against excessive gestational weight gain. The area under the ROC curve of the model was 0.885, the mean value of ten-fold cross-validation was 0.857 for AUC.

Conclusion: The nomogram model developed in this study has a good degree of discrimination and calibration, providing a valuable basis for early identification and precise intervention in individuals at risk of excessive gestational weight gain.

背景:妊娠期体重增加过多是一个全球性的公共卫生问题,对孕产妇和后代健康有严重和长期的影响。早期识别高危人群和干预措施对于控制体重增加和减少妊娠期体重过度增加的流行至关重要。目前,中国缺乏预测妊娠期体重过度增加风险的工具。本研究旨在建立一种风险预测模型和筛查工具,在早期阶段识别高危人群。方法:随机选取2023年1月至3月在中国某三级医院进行常规产科检查的孕妇306例。采用Logistic回归分析构建风险预测模型。采用Hosmer-Lemeshow检验评估模型的拟合优度,采用受试者工作特征(ROC)曲线下面积、校正图和k-fold交叉验证评估模型的预测性能。采用R4.3.1软件绘制图。结果:妊娠期体重超标的发生率为50.32%。Logistic回归分析显示,孕前超重(OR = 2.563, 95% CI: 1.043 ~ 6.299)、肥胖(OR = 4.116, 95% CI: 1.396 ~ 12.141)、在屏幕前进食(OR = 6.230, 95% CI: 2.753 ~ 14.097);每周食用含糖饮料/甜点/西式快餐的频率(OR = 1.948, 95% CI: 1.363-2.785);妊娠体像(OR = 1.030, 95% CI: 1.014-1.047)是妊娠期体重过度增加的危险因素。胎次(OR = 0.452, 95% CI: 0.275 - 0.740)、控制妊娠体重的保护性动机(OR = 0.979, 95% CI: 0.958-1)和每天中等强度体力活动的时间(OR = 0.228, 95% CI: 0.113-0.461)是防止妊娠体重过度增加的保护因素。模型的ROC曲线下面积为0.885,十倍交叉验证的AUC均值为0.857。结论:本研究建立的nomogram模型具有良好的辨析度和定标度,为早期识别和精准干预妊娠期体重增加过多风险个体提供了有价值的依据。
{"title":"Risk prediction of excessive gestational weight gain based on a nomogram model: a prospective observational study in China.","authors":"Linyan He, Xihong Zhou, Jiajun Tang, Min Yao, Li Peng, Sai Liu","doi":"10.1080/14767058.2024.2440774","DOIUrl":"10.1080/14767058.2024.2440774","url":null,"abstract":"<p><strong>Background: </strong>Excessive Gestational Weight Gain is a global public health problem with serious and long-term effects on maternal and offspring health. Early identification of at-risk groups and interventions is crucial for controlling weight gain and reducing the prevalence of excessive gestational weight gain. Currently, tools for predicting the risk of excessive gestational weight gain are lacking in China. This study aimed to develop a risk-prediction model and screening tool to identify high-risk groups in the early stages.</p><p><strong>Methods: </strong>A total of 306 pregnant women were randomly selected who underwent regular obstetric checkups at a tertiary-level hospital in China between January and March 2023. Logistic regression analysis was used to construct the risk-prediction model. The goodness of fit of the model was assessed using the Hosmer-Lemeshow test, and the predictive performance was evaluated using the area under the receiver operating characteristic (ROC) curve, calibration plots, and k-fold cross-validation. R4.3.1 software was used to create a nomogram.</p><p><strong>Results: </strong>The prevalence of excessive gestational weight gain was 50.32%. Logistic regression analysis revealed that pre-pregnancy overweight (OR = 2.563, 95% CI: 1.043-6.299), obesity (OR = 4.116, 95% CI: 1.396-12.141), eating in front of a screen (OR = 6.230, 95% CI: 2.753 - 14.097); frequency of weekly consumption of sugar-sweetened beverages/desserts/western fast food (OR = 1.948, 95% CI: 1.363-2.785); and pregnancy body image (OR = 1.030, 95% CI: 1.014-1.047) were risk factors for excessive gestational weight gain. Parity (OR = 0.452, 95% CI: 0.275 - 0.740), protective motivation to manage pregnancy body mass (OR = 0.979, 95% CI: 0.958-1), and the time of daily moderate-intensity physical activity (OR = 0.228, 95% CI: 0.113-0.461) were protective factors against excessive gestational weight gain. The area under the ROC curve of the model was 0.885, the mean value of ten-fold cross-validation was 0.857 for AUC.</p><p><strong>Conclusion: </strong>The nomogram model developed in this study has a good degree of discrimination and calibration, providing a valuable basis for early identification and precise intervention in individuals at risk of excessive gestational weight gain.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"38 1","pages":"2440774"},"PeriodicalIF":1.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142899729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mode of birth in nulliparous term singleton pregnancies in vertex presentation before and after implementation of an evidence-based intervention: quality-improvement study. 无产足月单胎妊娠顶点呈现前后的出生方式:循证干预:质量改善研究
IF 1.7 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-01 Epub Date: 2025-01-02 DOI: 10.1080/14767058.2024.2443968
Petra Psenkova, M Veliskova, D Dzubinska, I Waczulikova, M Tedla, P Peskovicova, J Zahumensky

Purpose: The main objective of this study was to assess the impact of a composite quality improvement intervention on mode of birth in nullipara term singleton vertex (NTSVs).

Material and methods: This was an ambidirectional study following the implementation of the intervention to reduce cesarean section rate in NSTV by comparing two birth cohorts, pre-composite quality improvement intervention cohort (January 2013-December 2015) and post-composite quality improvement intervention cohort (January 2018-December 2020).

Results: In the studied periods, there was a total of 7713 NTSV births. Compared to pre-composite quality improvement intervention, there was a post-composite quality improvement intervention reduction in NTSV cesarean section rate from 30.89% to 13.31% (p < 0.0001). Obstetric and non-obstetric indications for elective cesarean sections decreased from 5.52% to 1.04% (p < 0.0001) and from 4.82% to 0.52% (p < 0.0001), respectively. The frequency of emergency cesarean sections in this group decreased from 20.56% to 11.75% (p < 0.0001), especially those performed for failure to progress in labor (from 13.69% to 7.30%; p < 0.0001). There has been a rising trend with regards to maternal age. However, the proportion of mothers aged 35 years and more giving birth by cesarean section reduced from 46.94% to 20.28%. These reductions in cesarean section rates occurred without any negative impact on core fetal outcomes.

Conclusions: This quality improvement study demonstrates that it is feasible to significantly reduce cesarean section rate in NTSV by adopting specific composite measures. However, this requires the understanding of the inherent problems and barriers within the unit and the involvement of all stake holders.

目的:本研究的主要目的是评估综合质量改善干预对无产单胎顶点(ntsv)出生方式的影响。材料与方法:本研究是一项实施降低非stv剖宫产率干预后的双向研究,通过比较两个出生队列,复合前质量改善干预队列(2013年1月- 2015年12月)和复合后质量改善干预队列(2018年1月- 2020年12月)。结果:研究期间共发生NTSV分娩7713例。与复合前质量改善干预相比,复合后质量改善干预将NTSV剖宫产率从30.89%降低至13.31% (p p p p p)。结论:本质量改善研究表明,通过采取针对性的复合措施,显著降低NTSV剖宫产率是可行的。然而,这需要了解单位内部固有的问题和障碍,以及所有利益相关者的参与。
{"title":"Mode of birth in nulliparous term singleton pregnancies in vertex presentation before and after implementation of an evidence-based intervention: quality-improvement study.","authors":"Petra Psenkova, M Veliskova, D Dzubinska, I Waczulikova, M Tedla, P Peskovicova, J Zahumensky","doi":"10.1080/14767058.2024.2443968","DOIUrl":"https://doi.org/10.1080/14767058.2024.2443968","url":null,"abstract":"<p><strong>Purpose: </strong>The main objective of this study was to assess the impact of a composite quality improvement intervention on mode of birth in nullipara term singleton vertex (NTSVs).</p><p><strong>Material and methods: </strong>This was an ambidirectional study following the implementation of the intervention to reduce cesarean section rate in NSTV by comparing two birth cohorts, pre-composite quality improvement intervention cohort (January 2013-December 2015) and post-composite quality improvement intervention cohort (January 2018-December 2020).</p><p><strong>Results: </strong>In the studied periods, there was a total of 7713 NTSV births. Compared to pre-composite quality improvement intervention, there was a post-composite quality improvement intervention reduction in NTSV cesarean section rate from 30.89% to 13.31% (<i>p</i> < 0.0001). Obstetric and non-obstetric indications for elective cesarean sections decreased from 5.52% to 1.04% (<i>p</i> < 0.0001) and from 4.82% to 0.52% (<i>p</i> < 0.0001), respectively. The frequency of emergency cesarean sections in this group decreased from 20.56% to 11.75% (<i>p</i> < 0.0001), especially those performed for failure to progress in labor (from 13.69% to 7.30%; <i>p</i> < 0.0001). There has been a rising trend with regards to maternal age. However, the proportion of mothers aged 35 years and more giving birth by cesarean section reduced from 46.94% to 20.28%. These reductions in cesarean section rates occurred without any negative impact on core fetal outcomes.</p><p><strong>Conclusions: </strong>This quality improvement study demonstrates that it is feasible to significantly reduce cesarean section rate in NTSV by adopting specific composite measures. However, this requires the understanding of the inherent problems and barriers within the unit and the involvement of all stake holders.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"38 1","pages":"2443968"},"PeriodicalIF":1.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142923472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perinatal asphyxia-prevalence and risk factors: a cohort study in a neonatal intensive care unit in northeast Brazil. 围产期窒息患病率和危险因素:巴西东北部新生儿重症监护病房的队列研究。
IF 1.7 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-01 Epub Date: 2025-04-28 DOI: 10.1080/14767058.2025.2493731
Maria Goretti Policarpo Barreto, Cláudia Silva, Renata Policarpo Barreto, Roberta Policarpo Barreto, Lara Moreira Teles de Vasconcelos, Maria Conceição Manso

Objective: Even with all the worldwide effort in the care of pregnant women and newborns in the last 10 years, perinatal asphyxia remains a crucial public health problem worldwide, being responsible for the high rates of morbidity and mortality in term and preterm newborns. In this perspective, research was carried out which aimed to investigate the prevalence and analyze the environmental and maternal-fetal risk factors associated with perinatal asphyxia.

Methods: This cohort study (2013-2018), corresponding to six years, was conducted in Fortaleza, Ceará, Brazil. The study involved 480 postpartum women living in a capital in the Northeast of Brazil, whose newborns were admitted to the neonatal intensive care unit of a private referral hospital for high-risk pregnancies. Perinatal asphyxia in live births was taken as the dependent variable. To identify risk factors associated with perinatal asphyxia, bivariate and multivariate analyses were performed.

Results: The research showed a high prevalence of perinatal asphyxia. The final multivariate analysis showed a significant association between perinatal asphyxia and eclampsia and complications in labor (p < 0.05), these being preventable causes of this outcome. The research demonstrated a high prevalence of perinatal asphyxia and a significant association between perinatal asphyxia and complications in labor, eclampsia, and cesarean sections (p < 0.05), being preventable causes of this outcome.

Conclusion: The study gave greater visibility to prenatal care, and understanding complications during pregnancy and childbirth care. The publication of the results signaled to managers the need to implement public and private politics to face this problem, which promoted improvements in the living conditions of the population and the care of pregnant women, to reduce the births of babies with perinatal asphyxia, consequently, reducing neonatal and infant mortality.

目的:尽管在过去十年中全世界都在努力照顾孕妇和新生儿,但围产期窒息仍然是世界范围内一个重要的公共卫生问题,是足月新生儿和早产儿发病率和死亡率高的原因。因此,本研究旨在调查围产期窒息的患病率,并分析与围产期窒息相关的环境及母胎危险因素。方法:本队列研究(2013-2018)在巴西塞埃尔福塔莱萨进行,为期6年。这项研究涉及巴西东北部一个首都的480名产后妇女,她们的新生儿被送入一家高风险妊娠私人转诊医院的新生儿重症监护室。以活产围产儿窒息为因变量。为了确定与围产期窒息相关的危险因素,进行了双变量和多变量分析。结果:围产儿窒息发生率高。最后的多因素分析显示围产期窒息和子痫与分娩并发症之间存在显著相关性(p)结论:该研究提高了产前护理的可视性,并了解了妊娠和分娩护理期间的并发症。调查结果的公布向管理人员发出信号,表明有必要通过公共和私人政治手段来解决这一问题,从而促进改善人口的生活条件和对孕妇的护理,减少围产期窒息婴儿的出生,从而降低新生儿和婴儿死亡率。
{"title":"Perinatal asphyxia-prevalence and risk factors: a cohort study in a neonatal intensive care unit in northeast Brazil.","authors":"Maria Goretti Policarpo Barreto, Cláudia Silva, Renata Policarpo Barreto, Roberta Policarpo Barreto, Lara Moreira Teles de Vasconcelos, Maria Conceição Manso","doi":"10.1080/14767058.2025.2493731","DOIUrl":"https://doi.org/10.1080/14767058.2025.2493731","url":null,"abstract":"<p><strong>Objective: </strong>Even with all the worldwide effort in the care of pregnant women and newborns in the last 10 years, perinatal asphyxia remains a crucial public health problem worldwide, being responsible for the high rates of morbidity and mortality in term and preterm newborns. In this perspective, research was carried out which aimed to investigate the prevalence and analyze the environmental and maternal-fetal risk factors associated with perinatal asphyxia.</p><p><strong>Methods: </strong>This cohort study (2013-2018), corresponding to six years, was conducted in Fortaleza, Ceará, Brazil. The study involved 480 postpartum women living in a capital in the Northeast of Brazil, whose newborns were admitted to the neonatal intensive care unit of a private referral hospital for high-risk pregnancies. Perinatal asphyxia in live births was taken as the dependent variable. To identify risk factors associated with perinatal asphyxia, bivariate and multivariate analyses were performed.</p><p><strong>Results: </strong>The research showed a high prevalence of perinatal asphyxia. The final multivariate analysis showed a significant association between perinatal asphyxia and eclampsia and complications in labor (<i>p</i> < 0.05), these being preventable causes of this outcome. The research demonstrated a high prevalence of perinatal asphyxia and a significant association between perinatal asphyxia and complications in labor, eclampsia, and cesarean sections (<i>p</i> < 0.05), being preventable causes of this outcome.</p><p><strong>Conclusion: </strong>The study gave greater visibility to prenatal care, and understanding complications during pregnancy and childbirth care. The publication of the results signaled to managers the need to implement public and private politics to face this problem, which promoted improvements in the living conditions of the population and the care of pregnant women, to reduce the births of babies with perinatal asphyxia, consequently, reducing neonatal and infant mortality.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"38 1","pages":"2493731"},"PeriodicalIF":1.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144043409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors of bronchopulmonary dysplasia depending on the severity of the disease in very preterm infants. 极早产儿支气管肺发育不良的危险因素取决于疾病的严重程度。
IF 1.7 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-01 Epub Date: 2025-05-13 DOI: 10.1080/14767058.2025.2501697
Anna O Menshykova, Dmytro O Dobryanskyy

Objective: Bronchopulmonary dysplasia (BPD) remains a common pathology in very preterm infants. The risk of complications increases with the severity of the disease.The study aimed to determine the factors affecting the formation of moderate/severe BPD in the modern population of very preterm infants.

Methods: Data from 201 very low birth weight infants < 32 weeks of gestation were used in a retrospective cohort study. Infants were retrospectively divided into two groups based on the type of respiratory support at 36 weeks of postmenstrual age (PMA) - mild BPD (133 infants) and moderate/severe BPD (68 infants). The influence of major perinatal risk factors, neonatal morbidity, and medical interventions on the development of moderate/severe BPD was assessed.

Results: The groups were different in the incidence of intrauterine growth restriction (5% vs. 15%; p = 0.02), maternal hypertension (5% vs. 18%; p = 0.004), cesarean section (29% vs. 43%; p = 0.04), severe intraventricular hemorrhage (9% vs. 19%; p = 0.04), and retinopathy of prematurity (5% vs. 18%; p = 0.002), as well as in need for chest compressions during resuscitation at birth (2% vs. 9%; p = 0.01) for mild and moderate/severe BPD, respectively. Infants in the moderate/severe BPD group had lower Apgar scores at 1 and 5 min, required longer mechanical ventilation (220 (10-1904) hours vs. 72 (1-614) hours; p < 0.0001), CPAP duration (456 (16-1320) hours vs. 278 (10-1200) hours; p = 0.0002), oxygen supply (50 (3-146) days vs. 29 (2-68) days; p < 0.0001), as well as antibacterial therapy (61 (16-177) days vs. 52 (9-121) days; p = 0.0001) and hospital stay (109 (59-321) days vs. 85 (45-205) days; p < 0.0001). Infants with more severe BPD were also significantly more likely to die after reaching the PMA of 36 weeks (12% vs. 1%; p = 0.0003).According to the multivariable logistic regression analysis, the moderate/severe BPD was reliably and independently determined by maternal hypertension (aOR 4.53, 95% CI 1.48-13.91) and genitourinary infections (aOR 4.41, 95% CI 1.41-13.78), as well as the duration of CPAP (aOR 1.002, 95% CI 1.001-1.004) and mechanical ventilation (aOR 1.006, 95% CI 1.004-1.009).

Conclusions: Duration of respiratory support is the main risk factor that determines the development of moderate/severe BPD in the modern population of very preterm infants. Maternal hypertension and genitourinary infections may influence the severity of lung injury.

目的:支气管肺发育不良(BPD)仍然是非常早产儿的常见病理。并发症的风险随着疾病的严重程度而增加。该研究旨在确定影响现代极早产儿中中度/重度BPD形成的因素。方法:回顾性队列研究采用201例妊娠期< 32周的极低出生体重儿的数据。根据经后36周(PMA)呼吸支持的类型,将婴儿回顾性分为两组——轻度BPD(133名婴儿)和中度/重度BPD(68名婴儿)。评估主要围产期危险因素、新生儿发病率和医疗干预对中重度BPD发展的影响。结果:两组在宫内生长受限发生率上存在差异(5% vs. 15%;P = 0.02),产妇高血压(5% vs. 18%;P = 0.004),剖宫产(29% vs. 43%;P = 0.04),严重脑室内出血(9% vs. 19%;P = 0.04),早产儿视网膜病变(5% vs. 18%;P = 0.002),以及出生时复苏时需要胸外按压(2% vs. 9%;p = 0.01),分别为轻度和中度/重度BPD。中度/重度BPD组婴儿在1分钟和5分钟时Apgar评分较低,需要更长的机械通气时间(220(10-1904)小时对72(1-614)小时;P P = 0.0002),供氧(50(3-146)天vs. 29(2-68)天;P = 0.0001)和住院时间(109(59-321)天和85(45-205)天;p = 0.0003)。根据多变量logistic回归分析,产妇高血压(aOR 4.53, 95% CI 1.48-13.91)和泌尿生殖系统感染(aOR 4.41, 95% CI 1.41-13.78)以及CPAP持续时间(aOR 1.002, 95% CI 1.001-1.004)和机械通气(aOR 1.006, 95% CI 1.004-1.009)可靠且独立地决定了中/重度BPD。结论:呼吸支持持续时间是决定现代极早产儿中重度BPD发展的主要危险因素。产妇高血压和泌尿生殖系统感染可能影响肺损伤的严重程度。
{"title":"Risk factors of bronchopulmonary dysplasia depending on the severity of the disease in very preterm infants.","authors":"Anna O Menshykova, Dmytro O Dobryanskyy","doi":"10.1080/14767058.2025.2501697","DOIUrl":"https://doi.org/10.1080/14767058.2025.2501697","url":null,"abstract":"<p><strong>Objective: </strong>Bronchopulmonary dysplasia (BPD) remains a common pathology in very preterm infants. The risk of complications increases with the severity of the disease.The study aimed to determine the factors affecting the formation of moderate/severe BPD in the modern population of very preterm infants.</p><p><strong>Methods: </strong>Data from 201 very low birth weight infants < 32 weeks of gestation were used in a retrospective cohort study. Infants were retrospectively divided into two groups based on the type of respiratory support at 36 weeks of postmenstrual age (PMA) - mild BPD (133 infants) and moderate/severe BPD (68 infants). The influence of major perinatal risk factors, neonatal morbidity, and medical interventions on the development of moderate/severe BPD was assessed.</p><p><strong>Results: </strong>The groups were different in the incidence of intrauterine growth restriction (5% vs. 15%; <i>p</i> = 0.02), maternal hypertension (5% vs. 18%; <i>p</i> = 0.004), cesarean section (29% vs. 43%; <i>p</i> = 0.04), severe intraventricular hemorrhage (9% vs. 19%; <i>p</i> = 0.04), and retinopathy of prematurity (5% vs. 18%; <i>p</i> = 0.002), as well as in need for chest compressions during resuscitation at birth (2% vs. 9%; <i>p</i> = 0.01) for mild and moderate/severe BPD, respectively. Infants in the moderate/severe BPD group had lower Apgar scores at 1 and 5 min, required longer mechanical ventilation (220 (10-1904) hours vs. 72 (1-614) hours; <i>p</i> < 0.0001), CPAP duration (456 (16-1320) hours vs. 278 (10-1200) hours; <i>p</i> = 0.0002), oxygen supply (50 (3-146) days vs. 29 (2-68) days; <i>p</i> < 0.0001), as well as antibacterial therapy (61 (16-177) days vs. 52 (9-121) days; <i>p</i> = 0.0001) and hospital stay (109 (59-321) days vs. 85 (45-205) days; <i>p</i> < 0.0001). Infants with more severe BPD were also significantly more likely to die after reaching the PMA of 36 weeks (12% vs. 1%; <i>p</i> = 0.0003).According to the multivariable logistic regression analysis, the moderate/severe BPD was reliably and independently determined by maternal hypertension (aOR 4.53, 95% CI 1.48-13.91) and genitourinary infections (aOR 4.41, 95% CI 1.41-13.78), as well as the duration of CPAP (aOR 1.002, 95% CI 1.001-1.004) and mechanical ventilation (aOR 1.006, 95% CI 1.004-1.009).</p><p><strong>Conclusions: </strong>Duration of respiratory support is the main risk factor that determines the development of moderate/severe BPD in the modern population of very preterm infants. Maternal hypertension and genitourinary infections may influence the severity of lung injury.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"38 1","pages":"2501697"},"PeriodicalIF":1.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144048388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perspective in diagnostic accuracy of prenatal ultrasound and MRI for placenta accreta. 产前超声和MRI对增生性胎盘诊断准确性的探讨。
IF 1.7 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-01 Epub Date: 2025-02-23 DOI: 10.1080/14767058.2025.2463401
Qiu-Min Yang, Chu Zhang, Yun-Yun Zhang, Cai-Ning Liu

Purpose: Placenta accreta (PA) significantly increases the risk of life-threatening maternal outcomes, and its rising prevalence, driven by the increase in cesarean deliveries, underscores the need for precise diagnostic tools to improve clinical management and outcomes. This study aims to evaluate the advanced diagnostic capabilities of prenatal ultrasound and magnetic resonance imaging (MRI) in the detection of PA, a severe obstetric complication characterized by abnormal adherence of the placenta to the myometrium.

Materials and methods: The study utilized a review of current literature and clinical studies to assess the diagnostic accuracy and clinical utility of ultrasound and MRI in identifying PA. Both imaging modalities were evaluated for their ability to assess the depth and extent of placental invasion, as well as their complementary roles in prenatal diagnosis. The experimental system included detailed imaging protocols for ultrasound and MRI, focusing on placental and uterine structures, and their application in real-world clinical settings.

Results: The findings demonstrate that ultrasound and MRI are highly effective in diagnosing PA, with each modality offering unique advantages. Ultrasound is widely accessible and serves as the first-line diagnostic tool, providing detailed visualization of placental adherence and vascular patterns. MRI, on the other hand, offers superior soft tissue contrast and is particularly valuable in complex cases or when ultrasound findings are inconclusive. Together, these imaging techniques enable accurate evaluation of placental invasion, facilitating timely and targeted prenatal interventions. The study also highlights the potential for improved maternal and fetal outcomes through early diagnosis and optimized pregnancy management.

Conclusions: Prenatal ultrasound and MRI are indispensable tools in the diagnosis and management of placenta accreta, offering complementary insights that enhance diagnostic precision. Their combined use allows for detailed assessment of placental and uterine structures, guiding clinical decision-making and improving outcomes for both mothers and infants. Future advancements in imaging technology and research hold promise for further enhancing diagnostic accuracy and expanding clinical applications, ultimately contributing to safer and more effective care for patients with PA.

目的:胎盘增生(PA)显著增加危及生命的孕产妇结局的风险,其患病率上升,由剖宫产的增加驱动,强调需要精确的诊断工具来改善临床管理和结局。本研究旨在评估产前超声和磁共振成像(MRI)检测PA的先进诊断能力,PA是一种以胎盘与子宫肌层异常粘附为特征的严重产科并发症。材料和方法:本研究回顾了目前的文献和临床研究,以评估超声和MRI诊断PA的准确性和临床应用。两种成像方式评估其评估胎盘侵入的深度和程度的能力,以及它们在产前诊断中的补充作用。实验系统包括详细的超声和MRI成像方案,重点关注胎盘和子宫结构,以及它们在现实世界临床环境中的应用。结果:结果表明超声和MRI在诊断PA方面非常有效,每种方式都有其独特的优势。超声是广泛使用和作为一线诊断工具,提供详细的可视化胎盘粘附和血管模式。另一方面,MRI提供了优越的软组织对比,在复杂病例或超声结果不确定时特别有价值。总之,这些成像技术能够准确评估胎盘侵犯,促进及时和有针对性的产前干预。该研究还强调了通过早期诊断和优化妊娠管理改善孕产妇和胎儿结局的潜力。结论:产前超声和MRI是诊断和处理胎盘不可缺少的工具,两者互为补充,可提高诊断精度。它们的联合使用允许对胎盘和子宫结构进行详细评估,指导临床决策并改善母亲和婴儿的结果。成像技术和研究的未来进步有望进一步提高诊断准确性和扩大临床应用,最终为PA患者提供更安全、更有效的护理。
{"title":"Perspective in diagnostic accuracy of prenatal ultrasound and MRI for placenta accreta.","authors":"Qiu-Min Yang, Chu Zhang, Yun-Yun Zhang, Cai-Ning Liu","doi":"10.1080/14767058.2025.2463401","DOIUrl":"10.1080/14767058.2025.2463401","url":null,"abstract":"<p><strong>Purpose: </strong>Placenta accreta (PA) significantly increases the risk of life-threatening maternal outcomes, and its rising prevalence, driven by the increase in cesarean deliveries, underscores the need for precise diagnostic tools to improve clinical management and outcomes. This study aims to evaluate the advanced diagnostic capabilities of prenatal ultrasound and magnetic resonance imaging (MRI) in the detection of PA, a severe obstetric complication characterized by abnormal adherence of the placenta to the myometrium.</p><p><strong>Materials and methods: </strong>The study utilized a review of current literature and clinical studies to assess the diagnostic accuracy and clinical utility of ultrasound and MRI in identifying PA. Both imaging modalities were evaluated for their ability to assess the depth and extent of placental invasion, as well as their complementary roles in prenatal diagnosis. The experimental system included detailed imaging protocols for ultrasound and MRI, focusing on placental and uterine structures, and their application in real-world clinical settings.</p><p><strong>Results: </strong>The findings demonstrate that ultrasound and MRI are highly effective in diagnosing PA, with each modality offering unique advantages. Ultrasound is widely accessible and serves as the first-line diagnostic tool, providing detailed visualization of placental adherence and vascular patterns. MRI, on the other hand, offers superior soft tissue contrast and is particularly valuable in complex cases or when ultrasound findings are inconclusive. Together, these imaging techniques enable accurate evaluation of placental invasion, facilitating timely and targeted prenatal interventions. The study also highlights the potential for improved maternal and fetal outcomes through early diagnosis and optimized pregnancy management.</p><p><strong>Conclusions: </strong>Prenatal ultrasound and MRI are indispensable tools in the diagnosis and management of placenta accreta, offering complementary insights that enhance diagnostic precision. Their combined use allows for detailed assessment of placental and uterine structures, guiding clinical decision-making and improving outcomes for both mothers and infants. Future advancements in imaging technology and research hold promise for further enhancing diagnostic accuracy and expanding clinical applications, ultimately contributing to safer and more effective care for patients with PA.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"38 1","pages":"2463401"},"PeriodicalIF":1.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143484566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Maternal-Fetal & Neonatal Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1